Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy - Top-Institutions - MDSpire

Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy

  • By

  • Ming-Zhi Xiao

  • Xin-Xin Pang

  • Di Niu

  • Rui-Fang Chen

  • June 18, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    The First Affiliated Hospital of Henan University of Chinese Medicine
    The First Affiliated Hospital of Henan University of Chinese Medicine

    Zhengzhou, Henan

    Key Differentiators

    • Nephrology

  • #2

    Henan Provincial Hospital of Traditional Chinese Medicine
    Henan Provincial Hospital of Traditional Chinese Medicine

    Zhengzhou, Henan

    Key Differentiators

    • Nephrology

  • #3

    Swedish CArdioPulmonary BioImage Study
    Swedish CArdioPulmonary BioImage Study

    Sweden, N/A

    Key Differentiators

    • Nephrology

  • #4

    Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
    Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai

    Key Differentiators

    • Nephrology

  • #5

    Yancheng Third People’s Hospital
    Yancheng Third People’s Hospital

    Yancheng, Jiangsu

    Key Differentiators

    • Nephrology

Original Source(s)

Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy

  • by Ming-Zhi Xiao, Xin-Xin Pang, Di Niu, Rui-Fang Chen

  • June 18, 2026

Related Content

Staging and Practical Management of Diabetic Retinopathy

Approximately half of patients who have severe NPDR and nearly 75% of patients who have very severe NPDR will progress to PDR within 1 year.

Ultra-Widefield Color Fundus Photography in Diabetic Retinopathy: From Panretinal Assessment to Multimodal Integration

Retinal Age Model Tied to Disease Risk

Fundus-based tool estimates biologic aging but shows modest gains over prior models